Hillrom faces lawsuit after dropping planned $375M Bardy Diagnostics deal

Hillrom is calling off a planned acquisition of cardiac monitor-maker Bardy Diagnostics, saying the closing conditions of the deal had not been satisfied. The Chicago-based medical technology company announced its decision on Monday after Medicare Administrative Contractor Novitas Solutions slashed reimbursement for long-term cardiac monitoring.
Read more...

;